Illumina makes the DNA-sequencing machines behind most genetic research.
Illumina, Inc. (ILMN) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 16:10 ET. Consensus EPS estimate is $1.36.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | Jun 2026 qtr | $1.23 | $1.31 | +6.5% | $1.16B |
| 2026-04-30 | Mar 2026 qtr | $1.05 | $1.15 | +9.5% | $1.09B |
| 2026-02-05 | Dec 2025 qtr | $1.24 | $1.35 | +8.9% | $1.16B |
| 2025-10-30 | Sep 2025 qtr | $1.17 | $1.34 | +14.5% | $1.08B |
| 2025-07-31 | Jun 2025 qtr | $1.02 | $1.19 | — | $1.06B |
| 2025-05-08 | Mar 2025 qtr | $0.94 | $0.97 | +3.2% | $1.04B |
| 2025-02-06 | Dec 2024 qtr | $0.92 | $0.86 | -6.5% | $1.10B |
| 2024-11-04 | Sep 2024 qtr | $0.88 | $1.14 | — | $1.08B |
ILMN has beaten consensus EPS in 5 of its last 6 scored quarters.
See ILMN on the live calendar →